Understanding how a specific brain pathway helps reduce fear memories
Investigation of a thalamic-hippocampal pathway in contextual fear suppression and extinction
This study is looking at how certain parts of the brain work together to help people with PTSD manage their fear memories, with the hope of finding better treatments for those who struggle with this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11049794 on NIH RePORTER |
What this research studies
This research investigates the role of a brain pathway involving the thalamus and hippocampus in managing fear responses, particularly in individuals with post-traumatic stress disorder (PTSD). By using advanced imaging techniques, the study aims to uncover how certain brain regions interact to suppress and extinguish fear memories. This understanding could lead to new treatment strategies for PTSD, which currently affects many individuals and is often resistant to existing therapies. The research focuses on the neuronal mechanisms that underlie the retrieval and management of traumatic memories.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with PTSD who experience persistent fear responses related to traumatic events.
Not a fit: Patients without PTSD or those whose symptoms are not related to fear memory retrieval may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for PTSD, improving the quality of life for many patients.
How similar studies have performed: Previous research has shown promise in understanding brain mechanisms related to fear and anxiety, suggesting that this approach could yield valuable insights.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Sheffield, Mark E J — University of Chicago
- Study coordinator: Sheffield, Mark E J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.